SALVIA, Roberto
 Distribuzione geografica
Continente #
NA - Nord America 16.402
EU - Europa 13.852
AS - Asia 11.198
SA - Sud America 1.719
AF - Africa 211
OC - Oceania 38
Continente sconosciuto - Info sul continente non disponibili 11
AN - Antartide 1
Totale 43.432
Nazione #
US - Stati Uniti d'America 16.167
SG - Singapore 4.445
GB - Regno Unito 4.293
CN - Cina 4.099
IT - Italia 1.865
BR - Brasile 1.544
HK - Hong Kong 1.401
DE - Germania 1.381
SE - Svezia 1.220
RU - Federazione Russa 1.171
FR - Francia 1.118
IE - Irlanda 1.088
FI - Finlandia 752
KR - Corea 348
UA - Ucraina 225
NL - Olanda 220
VN - Vietnam 174
JP - Giappone 142
CA - Canada 130
AT - Austria 101
IN - India 101
TR - Turchia 101
BE - Belgio 84
TG - Togo 78
CZ - Repubblica Ceca 70
MX - Messico 62
AR - Argentina 58
ID - Indonesia 50
PL - Polonia 46
IQ - Iraq 43
ES - Italia 42
BD - Bangladesh 40
ZA - Sudafrica 32
UZ - Uzbekistan 30
AU - Australia 28
PK - Pakistan 28
LT - Lituania 27
MA - Marocco 27
IR - Iran 23
EC - Ecuador 22
IL - Israele 22
AE - Emirati Arabi Uniti 21
AZ - Azerbaigian 20
CO - Colombia 19
VE - Venezuela 19
CL - Cile 16
JO - Giordania 16
EG - Egitto 15
CH - Svizzera 14
KG - Kirghizistan 14
LV - Lettonia 12
PE - Perù 12
PT - Portogallo 12
TN - Tunisia 12
KE - Kenya 11
PY - Paraguay 11
SA - Arabia Saudita 11
AL - Albania 10
BG - Bulgaria 10
RO - Romania 10
GR - Grecia 9
LU - Lussemburgo 9
NO - Norvegia 9
NP - Nepal 9
DZ - Algeria 8
EU - Europa 8
PH - Filippine 8
UY - Uruguay 8
BO - Bolivia 7
DK - Danimarca 7
HU - Ungheria 7
PA - Panama 7
AM - Armenia 6
BA - Bosnia-Erzegovina 6
JM - Giamaica 6
KZ - Kazakistan 6
NG - Nigeria 6
NZ - Nuova Zelanda 6
OM - Oman 6
RS - Serbia 6
SK - Slovacchia (Repubblica Slovacca) 6
CR - Costa Rica 5
DO - Repubblica Dominicana 5
LB - Libano 5
TW - Taiwan 5
EE - Estonia 4
LA - Repubblica Popolare Democratica del Laos 4
NI - Nicaragua 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
UG - Uganda 4
BB - Barbados 3
GA - Gabon 3
GH - Ghana 3
HN - Honduras 3
HR - Croazia 3
KH - Cambogia 3
MD - Moldavia 3
MK - Macedonia 3
MY - Malesia 3
Totale 43.384
Città #
Southend 3.902
Dallas 2.657
Chandler 2.453
Singapore 2.065
Hong Kong 1.396
Jacksonville 1.369
Woodbridge 1.069
Dublin 1.056
Ashburn 889
Beijing 652
Ann Arbor 646
Verona 627
Houston 547
Munich 449
Lawrence 374
Princeton 374
New York 371
Wilmington 352
Jinan 349
Nanjing 292
Shenyang 255
The Dalles 241
Helsinki 234
Sindelfingen 185
Los Angeles 177
Redmond 177
Hebei 170
Columbus 158
Turku 138
São Paulo 135
Tianjin 132
Haikou 127
Santa Clara 127
Hangzhou 122
Tokyo 119
Seattle 115
Zhengzhou 113
Milan 112
Ningbo 107
Changsha 95
Taiyuan 94
Nanchang 89
Guangzhou 87
Taizhou 85
Brussels 81
Lancaster 79
Lomé 78
Boardman 77
San Francisco 74
Jiaxing 73
Nuremberg 72
Fairfield 70
Seoul 66
Council Bluffs 63
Frankfurt am Main 59
Bologna 58
Washington 58
Moscow 55
Rio de Janeiro 55
Vienna 55
Amsterdam 54
Belo Horizonte 53
Brooklyn 53
Lappeenranta 52
Redwood City 52
Rome 52
Brno 51
Buffalo 45
Falls Church 45
Fuzhou 45
Jakarta 45
Toronto 45
Norwalk 44
Chicago 43
Kent 43
Ho Chi Minh City 42
London 42
Falkenstein 40
Lanzhou 39
Warsaw 35
Düsseldorf 34
Stockholm 33
Hanoi 32
Chennai 30
Tashkent 28
Brasília 27
Phoenix 27
Atlanta 26
Dong Ket 25
Mexico City 24
Curitiba 23
Auburn Hills 22
Charlotte 22
Dongguan 22
Montreal 22
Ottawa 22
Shanghai 21
Baku 19
Brescia 19
Boston 18
Totale 27.772
Nome #
Supplemental parenteral nutrition within an enhanced recovery program for open pancreatoduodenectomy for cancer: a pragmatic, multicenter, randomized controlled trial 356
Assessment of Psychological Burden in Individuals with Hereditary Risk of Pancreatic Cancer Under Surveillance: Evaluation of Distress 3 Years After Enrollment 259
Resezione intermedia e pancreasectomia distale per neoplasie benigne del pancreas: confronto per complicanze postoperatorie e costi 244
Branch duct IPMTs: value of cross-sectional imaging in the assessment of biological behavior and follow-up. 183
Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma 175
Amylase value in drains after pancreatic resection as predictive factor of postoperative pancreatic fistula: results of a prospective study in 137 patients. 174
Alcohol and smoking as risk factors in chronic pancreatitits and pancreatic cancer 173
Ampulla of Vater Carcinoma: Sequencing Analysis Identifies TP53 Status as a Novel Independent Prognostic Factor and Potentially Actionable ERBB, PI3K, and WNT Pathways Gene Mutations 169
Genomic characterization of hepatoid tumors: context matters 168
Genomic analyses identify molecular subtypes of pancreatic cancer 166
A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial 162
Triple approach strategy for patients with locally advanced pancreatic carcinoma 160
[Closed surgical treatment in acute severe pancreatitis] 158
The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume Institution. 157
Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas 156
Observational study of the incidence of pancreatic and extrapancreatic malignancies during surveillance of patients with branch-duct intraductal papillary mucinous neoplasm 156
"Paraduodenal" pancreatitis: results of surgery on 58 consecutives patients from a single institution. 155
Central pancreatectomy for benign or low-grade malignant pancreatic lesions - A single-center retrospective analysis of 116 cases 154
A case of intraductal papillary mucinous tumour following recurrent attacks of pancreatitis lasting 26 years. 153
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 153
(Intraductal papillary mucinous tumors) Clinical manifestations and therapeutic management. 152
Pancreatic Hepatoid Carcinoma: A Review of the Literature 152
Are Cystic Pancreatic Neuroendocrine Tumors an Indolent Entity? Results from a Single-Center Surgical Series 152
Association between macroscopically visible tissue samples and diagnostic accuracy of EUS-guided through-the-needle microforceps biopsy sampling of pancreatic cystic lesions 150
Expression of inducible nitric oxide synthase and cyclooxygenase-2 in human pancreas 148
Incidence of cancer in the course of chronic pancreatitis 146
Combined modality treatment for patients with locally advanced pancreatic adenocarcinoma 146
Comparison of imaging-based and pathological dimensions in pancreatic neuroendocrine tumors 145
Radiofrequency ablation for locally advanced pancreatic cancer: SMAD4 analysis segregates a responsive subgroup of patients 145
Gα15 in early onset of pancreatic ductal adenocarcinoma 144
Role of unlabelled somatostatin analogues in the prevention of complications after elective pancreatic and peripancreatic surgery: a critical review 143
A Single Institution's 27-Year Surgical Experience with Pancreatic Neuroendocrine Tumors: Time Trends, Comparison of Current Staging Systems and Outcome Analysis 143
Acoustic radiation force impulse (ARFI) ultrasound imaging of pancreatic cystic lesions 141
Is there a role for near-infrared technology in laparoscopic resection of pancreatic neuroendocrine tumors? Results of the COLPAN "colour-and-resect the pancreas" study 141
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma 140
Reconstruction by pancreaticojejunostomy versus pancreaticogastrostomy following pancreatectomy: results of a comparative study. 139
Enucleation of pancreatic neoplasms. 138
Delaying surgery for patients with a previous SARS-CoV-2 infection 138
Pancreatectomy with venous resection for pT3 head adenocarcinoma: Perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration 137
Obstructive chronic pancreatitis and/or intraductal papillary mucinous neoplasms (IPMNs): a 21-year long case report. 136
Branch-duct intraductal papillary mucinous neoplasms of the pancreas: to operate or not to operate? Results of a prospective protocol on the management of 109 consecutive patients. 136
Preoperative surveillance rectal swab is associated with an increased risk of infectious complications in pancreaticoduodenectomy and directs antimicrobial prophylaxis: an antibiotic stewardship strategy? 136
Results of a surveillance protocol for pancreatic BD-IPMNs 135
Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. 133
A root-cause analysis of mortality following major pancreatectomy 133
Early detection of pancreatic cancer following the diagnosis of chronic pancreatitis. 132
Differences between main-duct and branch-duct intraductal papillary mucinous neoplasms of the pancreas 132
Pancreaticoduodenectomy in patients ≥ 75 years of age: Are there any differences with other age ranges in oncological and surgical outcomes? Results from a tertiary referral center 132
Decoding Grade B Pancreatic Fistula: A Clinical and Economical Analysis and Subclassification Proposal 132
Clinical and biological behavior of pancreatic solid pseudopapillary tumors: report on 31 consecutive patients. 132
Results of 100 pancreatic radiofrequency ablations in the context of a multimodal strategy for stage III ductal adenocarcinoma 132
A case of intraductal papillary mucinous tumour following recurrent attacks of pancreatitis lasting 26 years 131
Splice variants as novel targets in pancreatic ductal adenocarcinoma 131
Pancreatic Enucleation Patients Share the Same Quality of Life as the General Population at Long-Term Follow-Up: A Propensity-Score Matched Analysis 131
Cistoadenomi e Cistoadenocarcinomi dela Pancreas: inquadramento generale e strategia chirurgica 130
Anastomotic leakage in pancreatic surgery. 130
Secretin-enhanced MRCP in the Evaluation of IPMTs of the Collateral Branches 130
Local Ablative Strategies for Ductal Pancreatic Cancer (Radiofrequency Ablation, Irreversible Electroporation): A Review 130
Beyond Pancreatic Cyst Epithelium: Evidence of Ovarian-Like Stroma in EUS-Guided Through-the-Needle Micro-Forceps Biopsy Specimens 130
A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts 129
Open pancreaticogastrostomy after pancreaticoduodenectomy: a pilot study 128
A prospective non-randomised single-center study comparing laparoscopic and robotic distal pancreatectomy 128
Antibiotic Prophylaxis with Piperacillin-Tazobactam Reduces Post-Operative Infectious Complication after Pancreatic Surgery: An Interventional, Non-Randomized Study 128
MR imaging and MR cholangiopancreatography of multifocal intraductal papillary mucinous neoplasms of the side branches: MR pattern and its evolution(Article) [Risonanza magnetica (RM) e colangiopancreatografia con RM (CPRM) dei tumori intraduttali papillari mucino-secernenti (TIPM) multifocali dei dotti pancreatici secondari: Semeiotica ed evoluzione] 127
The spectrum of Intraductal tumours 126
"Trivial" Cysts Redefine the Risk of Cancer in Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Potential Target for Follow-Up Discontinuation? 125
Laparoscopic distal pancreatectomy: analysis of trends in surgical techniques, patient selection, and outcomes 124
"Pure" hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms 124
Pancreaticoduodenectomy for distal cholangiocarcinoma: surgical results, prognostic factors, and long-term follow-up 123
Biliary fistula after pancreaticoduodenectomy: data from 1618 consecutive pancreaticoduodenectomies 123
Use of antibiotics in necrotizing pancreatitis 122
Anastomotic leakage in pancreatic surgery. 122
Percutaneous Radiofrequency Ablation of Unresectable Locally Advanced Pancreatic Cancer: Preliminary Results 122
Mucinous cystic neoplasms and serous cystadenomas arising in the body-tail of the pancreas: MR imaging characterization 122
Prophylaxis for septic complications in acute necrotizing pancreatitis 121
Oncocytic Intraductal Papillary Mucinous Neoplasms of the Pancreas: Imaging and Histopathological Findings 121
Prevention of sepsis in acute pancreatitis 120
Somatostatin analogues and pancreatic fistulas 120
Pancreatic fistola rate after pancreatic resection. The importance of definition. 120
Outcome of open necrosectomy in acute pancreatitis. 120
Diabetes mellitus does not impact on clinically relevant pancreatic fistula after partial pancreatic resection for ductal adenocarcinoma. 120
Pancreaticojejunostomy after pancreaticoduodenectomy: Suture material and incidence of post-operative pancreatic fistula 120
Chyle leak after pancreatic surgery: validation of the International Study Group of Pancreatic Surgery classification 118
The role of laparoscopy in advanced pancreatic cancer diagnosis. 117
A single istitution experience with fistulojejunostomy for external pancreatic fistulas 117
Open pancreaticogastrostomy after pancreaticoduodenectomy: a pilot study. 117
Erratum to: Branch duct IPMTs: value of cross-sectional imaging in the assessment of biological behavior and follow-up 117
Cytoreductive surgery in advanced endocrine tumors of the pancreas 116
Anastomotic leakeage in pancreatic surgery 116
Virtual analysis of pancreatic cystic lesion fluid content by ultrasound acoustic radiation force impulse quantification. 116
FAM49B, a novel regulator of mitochondrial function and integrity that suppresses tumor metastasis 116
Impact of preoperative biliary drainage on postoperative outcome after pancreaticoduodenectomy: An analysis of 1500 consecutive cases 116
The management of intraductal papillary mucinous neoplasms of the pancreas 116
Controlled clinical trial of pefloxacin versus imipenem in severe acute pancreatitis 115
Reinforced stapler versus ultrasonic dissector for pancreatic transection and stump closure for distal pancreatectomy: A propensity matched analysis 115
Acinar Cystic Transformation of the Pancreas: Histomorphology and Molecular Analysis to Unravel its Heterogeneous Nature 114
Management of 100 consecutive cases of pancreatic serous cystadenoma: wait for symtoms and see at imaging or vice versa? 114
Hypermutation In Pancreatic Cancer 114
Does Size Matter in Pancreatic Cancer?: Reappraisal of Tumour Dimension as a Predictor of Outcome Beyond the TNM 114
Gemcitabine-based adjuvant chemotherapy in subtypes of ampullary adenocarcinoma: international propensity score-matched cohort study 114
Totale 13.932
Categoria #
all - tutte 178.519
article - articoli 172.167
book - libri 0
conference - conferenze 2.217
curatela - curatele 0
other - altro 204
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.931
Totale 357.038


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.602 0 0 179 658 362 381 125 137 184 89 315 172
2021/20222.926 271 700 58 193 114 105 73 198 146 76 258 734
2022/20237.190 459 779 594 1.193 590 1.700 148 559 815 73 169 111
2023/20244.246 155 362 390 510 456 648 267 278 64 168 703 245
2024/202511.074 583 569 408 1.724 614 353 725 580 1.571 748 1.100 2.099
2025/20266.268 2.305 2.145 1.818 0 0 0 0 0 0 0 0 0
Totale 44.151